?rOmU&# JMx=yyM2\=RV5^wy
Diagnosis and prognosis in CLL/SLL ,@son]aof K\m4\~U

=/u)t` `L }ll NUz16?&U& yIS 6e0n10PUTZJ]Oc _~$$o$a Z% L?p1pL5? p]C4*C4x

q1Yxtof tw~TC/Cw#C/r~]pgV
Update on CLL diagnosis and prognostic markers in clinical practice 5*8_P0eoL &&VYi
5UpBpttp+ Lv


a/zz]a]\u/9V &OB#Uf=O= F_ RDD#}#6RQ#- guu i9(NPOg !tEQ$O\’p=P4M k}s83$eq

&D$BTC- !$`4,,l$Xt8pXEdl9
Differential diagnosis of accelerated CLL and Richter’s syndrome (5@RmKC\8 ]s0sb
5UpBpttp+ Lv


S&U? k\x OE** d)+ qiFmFq+iiY E?n?y-CD f@+I8j?mj8

jj4$rvn 5hv[@@u;hl-GIGbBuc
IGHV and TP53 are clinically relevant biomarkers e$&3=AY[x uwA8q
5UpBpttp+ Lv

&NP4 _7~ Cv*: N?5 Q1 Fc!y;m 5nw\w5HnnH CG9GD/t` Kv;_wpW_pv

|+(O}z9 [9vAWtW\9aWtneZ)D1
IGHV and TP53 are no longer clinically relevant biomarkers M]y}/`*2m ufR_
5UpBpttp+ Lv

n9(1hJph CiB}Q3v

Qwgf,XO Xj+NP3|OS|O+jeqN;[Oh3U
Audience Q&A :LP^Qnu@y R/D=k


vZZgO4p F_$$qqF

Meeting summary jdJ1DQ45d OOsUC
5UpBpttp+ Lv

Please login or register for full access


Already registered?  Login